do i qualify for a glp 1 What Is Insurance Prior Authorization GLP-1s? GLP-1 Medications for Weight Loss:

Cureus 16 (1), e52194 (2024) S

This extensive research timeline provides substantial evidence regarding both short-term efficacy and longer-term safety considerations, though ongoing studies continue to expand our understanding of this medication's full clinical profile

doi: 10.1016/j.cocis.2020.101413 98 GhezziP

Participant characteristics by baseline incretin effect While all participants ( n = 30) had a 2-hour glucose level 120 mg/dL at baseline, 17 of the 30 participants (57%) maintained a 2-hour glucose level 120 mg/dL at the follow-up OGTT, with 10 of the 17 exhibiting impaired glucose tolerance (IGT) and 1 exhibiting overt diabetes

As a result, GHK-Cu should be viewed as a well-tolerated adjunct with promising data rather than a proven equivalent to prescription retinoids

2021;7:eabe7548